Bruker Corp (BRKR)
51.80
-2.69
(-4.94%)
USD |
NASDAQ |
Nov 15, 10:45
Bruker Cash and Short Term Investments (Quarterly): 148.10M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 148.10M |
| June 30, 2024 | 169.70M |
| March 31, 2024 | 340.10M |
| December 31, 2023 | 488.30M |
| September 30, 2023 | 363.60M |
| June 30, 2023 | 574.80M |
| March 31, 2023 | 597.90M |
| December 31, 2022 | 645.50M |
| September 30, 2022 | 626.20M |
| June 30, 2022 | 723.00M |
| March 31, 2022 | 916.10M |
| December 31, 2021 | 1.168B |
| September 30, 2021 | 669.80M |
| June 30, 2021 | 706.00M |
| March 31, 2021 | 746.80M |
| December 31, 2020 | 731.80M |
| September 30, 2020 | 617.10M |
| June 30, 2020 | 796.80M |
| March 31, 2020 | 851.70M |
| December 31, 2019 | 684.90M |
| September 30, 2019 | 302.40M |
| June 30, 2019 | 288.80M |
| March 31, 2019 | 298.80M |
| December 31, 2018 | 322.40M |
| September 30, 2018 | 270.10M |
| Date | Value |
|---|---|
| June 30, 2018 | 258.70M |
| March 31, 2018 | 283.90M |
| December 31, 2017 | 439.20M |
| September 30, 2017 | 429.20M |
| June 30, 2017 | 440.30M |
| March 31, 2017 | 464.50M |
| December 31, 2016 | 500.30M |
| September 30, 2016 | 441.50M |
| June 30, 2016 | 420.40M |
| March 31, 2016 | 420.50M |
| December 31, 2015 | 468.30M |
| September 30, 2015 | 532.30M |
| June 30, 2015 | 493.60M |
| March 31, 2015 | 492.30M |
| December 31, 2014 | 497.50M |
| September 30, 2014 | 442.30M |
| June 30, 2014 | 457.60M |
| March 31, 2014 | 454.00M |
| December 31, 2013 | 438.70M |
| September 30, 2013 | 306.80M |
| June 30, 2013 | 250.90M |
| March 31, 2013 | 269.40M |
| December 31, 2012 | 310.60M |
| September 30, 2012 | 242.10M |
| June 30, 2012 | 240.30M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
148.10M
Minimum
Sep 2024
1.168B
Maximum
Dec 2021
628.32M
Average
657.65M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Azenta Inc | 595.84M |
| Harvard Bioscience Inc | 4.569M |
| Bionano Genomics Inc | 18.94M |
| Akoya Biosciences Inc | 45.22M |
| Singular Genomics Systems Inc | 133.20M |